ANALYST COVERAGE
Jeffrey Osborne | Cowen & Co. | +1 (646) 562-1391 |
Amit Dayal | Rodman & Renshaw | +1 (212) 356-0517 |
SEC FILINGS
CORPORATE PRESENTATIONS
LEADERSHIP & GOVERNANCE
LEADERSHIP & GOVERNANCE
BioAmber Inc. has assembled a team of industry veterans in the fields of industrial biotechnology and chemicals. Having assembled unmatched experience and unrivalled technical and business acumen, BioAmber Inc. is positioned to lead the emergence of economically-viable, sustainable chemicals. The company has staffed its board of directors and management team with seasoned professionals possessing strong track records and complementary experience.
Directors
Senior Management
Board Committees
The management team is to promote sustainable development, ownership of issues, proper behavior, and innovative technology, all of which foster eco efficiency and a safe working environment. We are firmly committed to the pursuit of HSE excellence – not just for today but for the future.
The Company’s Board of Directors has established an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee, each of which operates pursuant to a charter adopted by our board of directors.
Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Audit Committee | Compensation Committee | Nominating and Corporate Governance Committee | |
---|---|---|---|
Kurt Briner | ![]() |
||
Heinz Haller | ![]() |
||
Ellen B. Richstone | ![]() |
![]() |
|
Kenneth W. Wall | ![]() |
![]() |
|
Robert Frost | ![]() |
||
Raymond J. Land | ![]() |
![]() |




Press Releases
Archives: Search / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008
Mar 27, 2018 BioAmber Inc. (OTCPK: BIOA) announced that it has scheduled a webcast and conference call for 8:00 am (EDT), Wednesday, March 28th, to discuss the fourth quarter and year end 2017 results. Live... More |
Mar 27, 2018 BioAmber Inc. (OTCPK: BIOA) today announced operational and financial results for the three months and year ended December 31, 2017. Q4 2017 Highlights: The fourth quarter revenue of $5.4 million... More |
Mar 15, 2018 BioAmber Inc. (OTCPK: BIOA) (the "Company") announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission (the "SEC") regarding a delay in the... More |
CALENDAR & EVENTS
VISION FOR GROWTH
Accelerating the global adoption of green chemicals
Our Strategic Priorities
- Rapidly Expand Global Manufacturing Capacity
- Target the Large and Established 1,4 Butanediol Market
- Develop Next-Generation Succinic-Derived Products
- Reduce Production Costs (Continuous Improvement)
- Expand Product Portfolio to Additional Building Block Chemicals